Yan Y P, Yin K J, Sun F Y
National Key Laboratory of Medical Neurobiology and Department of Neurobiology, Shanghai Medical University, China.
Neuroreport. 1998 Feb 16;9(3):441-6. doi: 10.1097/00001756-199802160-00016.
To study the effects of glutamate transporters on the pathogenesis of brain infarct, pharmacological and histological analyses were carried out on the thrombotic focal ischemic model. Expression of mRNA coding for the glutamate transporter GLAST increased significantly in the penumbra at 72 h following the ischemia. Combined with confocal laser scanning microscopic analysis, double staining showed expression of GLAST mRNA in both neurons and glial cells in the penumbra. L-trans-Pyrrolidine-2,4-dicarboxylate (L-trans-PDC), a glutamate uptake inhibitor, dose-dependently enhanced the volume of the infarct induced by the ischemia. The results suggest that a compensatory increase in the activity of glutamate transporter may accompany pathological changes after ischemic injury.
为研究谷氨酸转运体对脑梗死发病机制的影响,对血栓形成性局灶性缺血模型进行了药理学和组织学分析。编码谷氨酸转运体GLAST的mRNA在缺血后72小时时,其在半暗带中的表达显著增加。结合共聚焦激光扫描显微镜分析,双重染色显示半暗带中的神经元和胶质细胞均有GLAST mRNA表达。L-反式-吡咯烷-2,4-二羧酸(L-trans-PDC),一种谷氨酸摄取抑制剂,可剂量依赖性地增加缺血诱导的梗死体积。结果表明,缺血性损伤后,谷氨酸转运体活性的代偿性增加可能伴随病理变化。